Huan Xu

2.2k total citations
56 papers, 1.3k citations indexed

About

Huan Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Huan Xu has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Huan Xu's work include Epigenetics and DNA Methylation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Andrographolide Research and Applications (4 papers). Huan Xu is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Andrographolide Research and Applications (4 papers). Huan Xu collaborates with scholars based in China, United States and Croatia. Huan Xu's co-authors include Emily E. Bosco, Erik S. Knudsen, Lee A. Denson, Erin Bonkowski, Rebecca G. Carey, Ingrid Jurickova, Ying Wang, Jack T. Zilfou, Scott W. Lowe and Bruce J. Aronow and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Huan Xu

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huan Xu China 22 638 376 333 240 186 56 1.3k
Wen-Jia Chen China 23 996 1.6× 523 1.4× 345 1.0× 192 0.8× 165 0.9× 101 1.6k
Guizhi Yang China 16 907 1.4× 259 0.7× 261 0.8× 172 0.7× 142 0.8× 29 1.6k
Wenting Xu China 18 872 1.4× 412 1.1× 424 1.3× 206 0.9× 168 0.9× 46 1.6k
Hui Shi China 20 496 0.8× 200 0.5× 380 1.1× 154 0.6× 246 1.3× 42 1.2k
Lijing Wang China 20 668 1.0× 299 0.8× 178 0.5× 126 0.5× 182 1.0× 66 1.2k
Funeng Jiang China 25 954 1.5× 564 1.5× 280 0.8× 330 1.4× 115 0.6× 65 1.5k
Xi Tang China 22 972 1.5× 562 1.5× 388 1.2× 125 0.5× 175 0.9× 53 1.6k
Baofu Zhang China 18 652 1.0× 281 0.7× 336 1.0× 210 0.9× 225 1.2× 49 1.2k
Xiaoqi Wang China 22 905 1.4× 248 0.7× 245 0.7× 119 0.5× 318 1.7× 66 1.4k
Hongtao Lu China 18 747 1.2× 246 0.7× 283 0.8× 145 0.6× 375 2.0× 65 1.6k

Countries citing papers authored by Huan Xu

Since Specialization
Citations

This map shows the geographic impact of Huan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huan Xu more than expected).

Fields of papers citing papers by Huan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huan Xu. The network helps show where Huan Xu may publish in the future.

Co-authorship network of co-authors of Huan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Huan Xu. A scholar is included among the top collaborators of Huan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huan Xu. Huan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Huan, Wei Li, Wenlong Fu, Zuoming Xie, & Wenmin Huang. (2025). Aquatic plant Myriophyllum spicatum displays contrasting morphological, photosynthetic, and transcriptomic responses between its aquatic and terrestrial morphotypes. Photosynthesis Research. 163(1). 15–15. 1 indexed citations
2.
Ju, Gaoda, Yaobin Lin, Xiaoxue Huang, et al.. (2025). TFDP1 drives triple-negative breast Cancer development through senescence suppression and serves as a therapeutic target for topotecan. International Journal of Biological Macromolecules. 310(Pt 4). 143543–143543. 1 indexed citations
3.
Li, Qiang-Ming, Huan Xu, Xue‐Qiang Zha, Fengyun Zhang, & Jian‐Ping Luo. (2025). Polygonatum cyrtonema polysaccharide alleviates dopaminergic neuron apoptosis in Parkinson's disease mouse model via inhibiting oxidative stress and endoplasmic reticulum stress. International Journal of Biological Macromolecules. 311(Pt 3). 143986–143986. 1 indexed citations
4.
Niu, Liangliang, Jiamin Liu, Huan Xu, et al.. (2024). Exposure to particulate matter (PM2.5) weakens corneal defense by downregulating thrombospondin-1 and tight junction proteins. Ecotoxicology and Environmental Safety. 287. 117276–117276. 1 indexed citations
5.
Wang, Xixi, Huiling Zhou, Huan Xu, et al.. (2024). Targeted and non-targeted proteomics to identify the urinary protein biomarkers for Wilson disease. Clinica Chimica Acta. 567. 120090–120090.
6.
Zhou, Jingjing, Yanhong Liu, Huan Xu, et al.. (2023). Exploring temporal trends and influencing factors for thyroid cancer in Guangzhou, China: 2004–2018. Endocrine. 84(2). 509–523. 1 indexed citations
9.
Xu, Huan, Zhixiao Liu, Yanting Shen, et al.. (2022). Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC). Molecular Metabolism. 59. 101466–101466. 12 indexed citations
10.
Jing, Jun, Huan Xu, Lingfan Xu, et al.. (2021). N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells. Journal for ImmunoTherapy of Cancer. 9(3). e002138–e002138. 25 indexed citations
12.
Cao, Zhi, Xiaolei Shi, Feng Tian, et al.. (2021). KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer. Cell Death and Disease. 12(1). 2–2. 40 indexed citations
13.
Wu, Ziqiang, Huan Xu, Yiming Xu, et al.. (2020). Andrographolide promotes skeletal muscle regeneration after acute injury through epigenetic modulation. European Journal of Pharmacology. 888. 173470–173470. 14 indexed citations
14.
15.
Yao, Huan, Shujun Wei, Ziqiang Wu, et al.. (2019). Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1/Smad Pathway. Evidence-based Complementary and Alternative Medicine. 2019. 1–14. 18 indexed citations
16.
Deng, Haoyuan, Xia Chu, Zhenfeng Song, et al.. (2017). MicroRNA-1185 Induces Endothelial Cell Apoptosis by Targeting UVRAG and KRIT1. Cellular Physiology and Biochemistry. 41(6). 2171–2182. 15 indexed citations
17.
Xu, Huan, Xu Zhao, Difei Bian, et al.. (2012). Madecassoside suppresses migration of fibroblasts from keloids: involvement of p38 kinase and PI3K signaling pathways. Burns. 38(5). 677–684. 43 indexed citations
18.
Lu, Dan, Yufeng Xia, Bei Tong, et al.. (2012). In vitro Anti-Angiogenesis Effects and Active Constituents of the Saponin Fraction From Gleditsia sinensis. Integrative Cancer Therapies. 13(5). 446–457. 11 indexed citations
19.
Carey, Rebecca G., Ingrid Jurickova, Edgar T. Ballard, et al.. (2007). Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflammatory Bowel Diseases. 14(4). 446–457. 126 indexed citations
20.
Bosco, Emily E., Ying Wang, Huan Xu, et al.. (2006). The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. Journal of Clinical Investigation. 117(1). 218–228. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026